Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC
Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC
Recruiting · NCT06864624 · Registry updated 2025-07-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC | non-small cell lung carcinoma | Recruiting | Phase 2 | 2025-07-25 | NCT06864624 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. | 4 |
| Tang-Du Hospital | 93 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| General Hospital of Ningxia Medical University | Yinchuan | China | 24 |
| Second Xiangya Hospital of Central South University | Changsha | China | 5 |
| Tangdu Hospital | Xi'an | China | 5 |